| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |